Wikidata

(Q61918601)

English

Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin

clinical trial

In more languages

Statements

title
Effects of Colesevelam HCl, Avandia® (Rosiglitazone Maleate), or JanuviaTM (Sitagliptin) on Glycemic Parameters and Lipid Profiles in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Monotherapy (English)
0 references
start time
May 2007
0 references
end time
April 2008
0 references
number of participants
169
0 references
research intervention
(RS)-rosiglitazone
0 references
metformin
0 references
sitagliptin phosphate
0 references
maleic acid
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61918601&oldid=2109358588"